Neurocrine Biosciences and Arena Pharmaceuticals Announce Receptor Collaboration SAN DIEGO, Sept. 15 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and Arena Pharmaceuticals, Inc. ("Arena"), a privately held biopharmaceutical company, today announced a collaboration involving the
Arena Pharmaceuticals, Inc. Announces Successful Completion of $17 Million Private Offering SAN DIEGO, Feb. 22 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Arena ), a privately-held biotechnology company, has announced the successful completion of a private offering through the sale of its